American Trust Amgen Inc Transaction History

American Trust

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 11, 2024	SELL	$268.87 - $324.56 $129,057 - $155,788	-480 Reduced 38.59%	764 $217,000
Q4 2023 Feb 21, 2024	BUY	$255.7 - $288.46 $318,090 - $358,844	1,244 New	1,244 $358,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $14,998 - $17,735	-70 Reduced 4.96%	1,341 $297,000
Q1 2023 May 22, 2023	BUY	$225.79 - $275.2 $8,354 - $10,182	37 Added 2.69%	1,411 $341,000
Q4 2022 Feb 16, 2023	BUY	$229.03 - $291.01 $93,215 - $118,441	407 Added 42.09%	1,374 $360,000
Q3 2022 Dec 02, 2022	SELL	$224.46 - $253.15 $6,733 - $7,594	-30 Reduced 3.01%	967 $218,000
Q2 2022 Oct 03, 2022	BUY	$230.71 - $256.74 $18,456 - $20,539	80 Added 8.72%	997 $243,000
Q1 2022 Jun 08, 2022	BUY	$219.27 - $242.57 $201,070 - $222,436	917 New	917 $222,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.